Caire Opens Global Service Headquarters
Caire opened a new Global Service Headquarters in Canton, Ga, near its primary manufacturing hub north of Atlanta.
Caire opened a new Global Service Headquarters in Canton, Ga, near its primary manufacturing hub north of Atlanta.
The medical advisory board of the Pulmonary Fibrosis Foundation issued a position statement on non-prescription supplemental oxygen.
Invacare Corp will discontinue production of its line of respiratory care products, which include oxygen concentrators, aerosol delivery devices, cannula, masks and tubing.
Emerging research shows that high-flow oxygen therapy could be enough support for many COVID-19 patients through to recovery.
Read MoreCaire is celebrating 20 years of patient access to portable oxygen concentrators after the...
Read MoreThe Caire portable oxygen concentrator FreeStyle Comfort outperformed other market leading devices in a study assessing COPD oxygen delivery.
Read MoreBelluscura has sold 377 units of its X-PLO2R portable oxygen concentrator since September 2021 — 25% above current consensus forecasts and 150% above initial forecasts for 2021.
Read MoreThe latest devices in humidification, inhaled nitric oxide, and oxygen therapy from Caire, Dynarex, Fisher & Paykel Healthcare, Masimo, NeoTech, Precision Medical, RapidOxygen, Southmedic, Vapotherm and Vero Biotech.
Read MoreCaire’s telehealth solution connects to the company’s oxygen concentrators via a patient’s smart device and simplifies remote data collection through a secure, cloud-based technology in real-time.
Read MoreResearchers at the National Institutes of Health have developed a prototype device that could potentially diagnose pregnancy complications by monitoring the oxygen level of the placenta.
Read MoreOxygen can be delivered through the wall of the intestine to compensate for the reduced availability of oxygen within the body that occurs in lung diseases.
Read MoreFor COPD patients receiving palliative care, oxygen therapy is provided to relieve hypoxia and dyspnea, improve quality of life, improve the patient’s ability to ambulate and/or exercise, and improve sleep by relieving nocturnal desaturations.
Read MoreRespiratory failure due to hypoxemia and/or hypercapnia calls for oxygen therapy, positive pressure support, and possibly ventilatory support. Care for these patients may escalate and require higher flow, FiO2, and more complex devices and intensive monitoring.
Read MoreThe US FDA has issued 510(k) clearance and marketing authorization to the X-plo2r portable oxygen concentrator from Belluscura PLC and Separation Design Group.
Read MoreBeginning this month, 3B Medical will give away six Aer X portable oxygen concentrators to patients with a demonstrated need for a POC device.
Read More